Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
Funding · Closes Jan 7, 2028
National Institutes of Health
Research grant
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
National Institutes of Health
- Up to $275,000
- Worldwide
- Institution applies
About
NIMH funds development of new or substantially improved brain-stimulation devices for mental health research and treatment applications. Relevant work includes greater spatial or temporal precision, closed-loop control and multi-site stimulation, with proof-of-concept hardware or software development. Clinical trials are not allowed. Support is up to USD 275,000 in direct costs over two years, with a USD 200,000 annual limit. The next new-application deadline is 16 October 2026 at 5 p.m. in the applicant organisation’s local time.
Topics
Eligibility
Covers: Up to USD 275,000 in direct costs over two years; no more than USD 200,000 in one year. Clinical trials are excluded.
US and non-US applicant organisations are eligible under this NOFO. International activities remain subject to current NIH policies and the call conditions.
Eligible higher-education, nonprofit, for-profit and other organisations listed in the NOFO, including non-US organisations, apply through their institution. Required institutional registrations and the NOFO-specific research conditions apply.
Source: grants.nih.gov